The safety and efficacy of laparoscopic hepatectomy in obese patients.


Journal

Asian journal of surgery
ISSN: 0219-3108
Titre abrégé: Asian J Surg
Pays: Netherlands
ID NLM: 8900600

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 09 09 2017
revised: 09 10 2017
accepted: 30 10 2017
pubmed: 24 12 2017
medline: 9 4 2019
entrez: 24 12 2017
Statut: ppublish

Résumé

Obesity is generally reported to increase the risk of surgical complications. There have been few reports of laparoscopic hepatectomy (LH) in obese patients. The purpose of this study was to compare the safety and efficacy of (1) LH versus open hepatectomy (OH) in obese patients and (2) LH in obese patients versus LH in non-obese patients. We introduced LH at our institution in April 2014. LH was performed in 63 obese patients and 108 non-obese patients from April 2014 to May 2017. OH was performed in 79 obese patients from January 2010 to May 2017. This study retrospectively compared the short-term outcomes of the LH obese group with those of the OH obese group and the LH non-obese group. In patient characteristics, the LH obese group included a significantly higher percentage of patients with liver cirrhosis than the OH obese group. The LH obese group had fewer patients with a history of abdominal surgery but more with liver cirrhosis than the LH non-obese group. For short-term outcomes, the LH obese group had significantly less blood loss, fewer intraoperative transfusions, fewer positive surgical margins, and shorter postoperative hospital stays than the OH obese group. In contrast, only operation time was significantly different (longer) in the LH obese group than in the LH non-obese group. There were no significant differences in morbidity or mortality between the LH obese group and either the OH obese or the LH non-obese groups. LH in obese patients is safe and effective.

Sections du résumé

BACKGROUND BACKGROUND
Obesity is generally reported to increase the risk of surgical complications. There have been few reports of laparoscopic hepatectomy (LH) in obese patients. The purpose of this study was to compare the safety and efficacy of (1) LH versus open hepatectomy (OH) in obese patients and (2) LH in obese patients versus LH in non-obese patients.
METHODS METHODS
We introduced LH at our institution in April 2014. LH was performed in 63 obese patients and 108 non-obese patients from April 2014 to May 2017. OH was performed in 79 obese patients from January 2010 to May 2017. This study retrospectively compared the short-term outcomes of the LH obese group with those of the OH obese group and the LH non-obese group.
RESULTS RESULTS
In patient characteristics, the LH obese group included a significantly higher percentage of patients with liver cirrhosis than the OH obese group. The LH obese group had fewer patients with a history of abdominal surgery but more with liver cirrhosis than the LH non-obese group. For short-term outcomes, the LH obese group had significantly less blood loss, fewer intraoperative transfusions, fewer positive surgical margins, and shorter postoperative hospital stays than the OH obese group. In contrast, only operation time was significantly different (longer) in the LH obese group than in the LH non-obese group. There were no significant differences in morbidity or mortality between the LH obese group and either the OH obese or the LH non-obese groups.
CONCLUSION CONCLUSIONS
LH in obese patients is safe and effective.

Identifiants

pubmed: 29273265
pii: S1015-9584(17)30479-7
doi: 10.1016/j.asjsur.2017.10.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-188

Informations de copyright

Copyright © 2017. Published by Elsevier Taiwan LLC.

Auteurs

Yusuke Ome (Y)

Department of Surgery, Kurashiki Central Hospital, Okayama, Japan. Electronic address: yusuke_omen@yahoo.co.jp.

Kazuki Hashida (K)

Department of Surgery, Kurashiki Central Hospital, Okayama, Japan.

Mitsuru Yokota (M)

Department of Surgery, Kurashiki Central Hospital, Okayama, Japan.

Yoshio Nagahisa (Y)

Department of Surgery, Kurashiki Central Hospital, Okayama, Japan.

Michio Okabe (M)

Department of Surgery, Kurashiki Central Hospital, Okayama, Japan.

Kazuyuki Kawamoto (K)

Department of Surgery, Kurashiki Central Hospital, Okayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH